Avertto Medical Ltd.

www.avertto.com

Formerly StrokeAlert

High-Tech Company

TECH VERTICALS

Stroke Analysis, Artificial Intelligence, Deep Learning, Detection, Digital Health, Healthtech, Life Sciences, MedTech, Monitoring, Sensors, Space Operations, SpaceTech

General Data

Sector	Digital Health
Company Stage:	R&D
Established	2019
Number of Employees	12
Reg. Number:	abCDe

DESCRIPTION

Avertto is developing a patented subcutaneous telemonitoring device for stroke prevention that uses an AI-powered algorithm to analyze carotid pulse wave changes and generate early alerts to healthcare providers.

TECHNOLOGY

Avertto develops a system uses artificial intelligence and deep learning technology to detect subtle changes in the patient’s pulse, which could indicate obstructions in the vessels, thereby serve as an early signal for a brain stroke. The company's device sends an alert, facilitating swift treatment within the “golden hour” that could avert severe stroke-related disability.

Products and Phases

Product	Phase
AMIT301	Phase I
An insertable medical device with an AI alert of impending strokes.

	TARGET MARKETS
	Elderly, Hopsitals, Healthcare providers.

	BUSINESS MODEL
	B2B

CONTACT INFO

Expand / Collapse All

Main Address: Moshav Aderet, Israel

City	Moshav Aderet
Country	Israel
Zip	9985000

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Dr. Hilla Ben-Pazi	CEO & Co-Founder
Mr. Yaniv Kirma	CTO	EndoWays (CEO)
Mr. Alan Rotman	Chief Hardware & Software Architect
Dr. Revital Shechter	Co-Founder
Mr. Avshalom Mizrahi	Co-Founder

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Board Member	CEO & Co-Founder, Avertto
abC Defghij	Board Member	CFO & SVP, Teva Global Operations, Teva Pharmaceuticals

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Jun. 01, 2024

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Government Agency	abCDe

R&D Grant

Sep. 01, 2023

R&D

abCDe

NIS 5m.

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Fund	abCDe

R&D Grant

Oct. 01, 2022

R&D

abCDe

NIS 2.5m.

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Fund	abCDe

R&D Grant

Jul. 01, 2022

R&D

abCDe

Euro 0.075

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Fund	abCDe

Last Updated:	abCDe
IVC Number:	abCDe